Shuttleworth, S., Silva, F., Cecil, A., Tomassi, C., Hill, T., Raynaud, F., . . . Workman, P. (2011). Progress in the Preclinical Discovery and Clinical Development of Class I and Dual Class I/IV Phosphoinositide 3-Kinase (PI3K) Inhibitors. Bentham Science Publishers Ltd.
Chicago-stil citatShuttleworth, S.J, F.A Silva, A.R.L Cecil, C.D Tomassi, T.J Hill, F.I Raynaud, P.A Clarke, och P. Workman. Progress in the Preclinical Discovery and Clinical Development of Class I and Dual Class I/IV Phosphoinositide 3-Kinase (PI3K) Inhibitors. Bentham Science Publishers Ltd, 2011.
MLA-referensShuttleworth, S.J, et al. Progress in the Preclinical Discovery and Clinical Development of Class I and Dual Class I/IV Phosphoinositide 3-Kinase (PI3K) Inhibitors. Bentham Science Publishers Ltd, 2011.